Is stem cell therapy for Muscular Dystrophy FDA-approved?
Product-specific gene therapies and medicines may be FDA-approved for defined muscular-dystrophy subtypes; that is not approval of generic stem-cell therapy. Verify the product, indication, genotype and label rather than accepting a broad regenerative claim.
How stem cells are studied for Muscular Dystrophy
Muscular dystrophies are a diverse group of inherited disorders, so diagnosis, affected gene, age, cardiac and respiratory status and disease stage determine appropriate care. Research spans gene replacement, exon skipping, gene editing, muscle progenitors and supportive-cell strategies. These mechanisms are different, and an MSC infusion does not correct an underlying pathogenic variant or reproduce an approved gene-targeted product.
Am I a candidate? → · Muscular Dystrophy: full overview → · Muscular Dystrophy cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.